top of page

Tutkimusnäyttö eri

   syöpälajeissa

Haimasyöpä

Wode, K., Kienle, G. S., Björ, O., Fransson, P., Sharp, L., Elander, N. O., Bernhardson, B.-M., Johansson, B., Ardnor, C. E., Scheibling, U., Nordberg, J. H., & Henriksson, R. (2024). Mistletoe Extract in Patients With Advanced Pancreatic Cancer. Dtsch Arztebl International, 121(11), 347-354. https://www.aerzteblatt.de/int/article.asp?id=239558

 

Hohneck, A. L., Sadikaj, L., Heinemann, L., Schroeder, M., Riess, H., Gerhards, A., Burkholder, I., Heckel-Reusser, S., Gottfried, J., & Hofheinz, R. D. (2023). Patients with Advanced Pancreatic Cancer Treated with Mistletoe and Hyperthermia in Addition to Palliative Chemotherapy: A Retrospective Single-Center Analysis. Cancers (Basel), 15(20). https://doi.org/10.3390/cancers15204929 
 

Oei SL and Schad F. (2023) Are Aspects of Integrative Concepts Helpful to Improve Pancreatic Cancer Therapy? Cancers. 2023; 15(4):1116. https://doi.org/10.3390/cancers15041116.

 

Kim BS, SEO Y, Kang CM. Alternative management of intractable chylous ascites following robot-assisted pancreaticoduodenectomy of Viscum album sclerotherapy: a case report. Korean Journal of Clinical Oncology 2022; 18(2): 78-82. DOI: https://doi.org/10.14216/kjco.22010

 

Wode, K., Hök Nordberg, J., Kienle, G.S.,  Elander N.O, Bernhardson B.-M., Sunde B., Sharp L., Henriksson R. et Fransson P. Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a multicentre, parallel group, double-blind, randomised, placebo-controlled clinical trial (MISTRAL). Trials 21, 783 (2020). https://doi.org/10.1186/s13063-020-04581-y

Thronicke A, Reinhold T, von Trott P, Matthes H & Schad F. Cost-Effectiveness of Real-World Administration of Concomitant Viscum album L. Therapy for the Treatment of Stage IV Pancreatic Cancer. Evid Based Complement Alternat Med. 2020;2020:3543568. Published 2020 Mar 12. doi: 10.1155/2020/3543568

 

Werthmann PG, Kempenich R, Lang-Avérous G, Kienle, GS. Long-term Survival of a Patient With Advanced Pancreatic Cancer Under Adjunct Treatment With Viscum album Extracts – A Case Report. World J Gastroenterol. March 2019. DOI: 10.3748/wjg.v25.i12.0000

 

Werthmann PG, Inter P, Welsch T, Sturm AK, Grutzmann R, Debus M, Sterner MG and Kienle GS. Long-term tumor-free survival in a metastatic pancreatic carcinoma patient with FOLFIRINOX/Mitomycin, high-dose, fever inducing Viscum album extracts and subsequent R0 resection: A case report. Medicine (Baltimore) 2018;97:e13243 

Bonucci M, Pastore C, Ferrera V, Fiorentini C, Fabbri A. Integrated cancer treatment in the course of metastatic pancreatic cancer: Complete resolution in 2 cases. Integrative Cancer Therapies 2018:17(3):994-999. DOI: 10.1177/1534735418755479 

Axtner J, Steele M, Kröz M, Spahn G, Matthes H and Schad F. Health services research of integrative oncology in palliative care of patients with advanced pancreatic cancer. BMC Cancer, 2016;16:579. DOI: 10.1186/s12885-016-2594-5

Tröger W, Galun D, Reif M, Schumann A, Stankovic N and Milicevic M. Quality of life of patients with advanced pancreatic cancer during treatment with mistletoe: a randomized controlled trial. Dtsch Arztebl Int, 2014;111:493-502, 433 p following 502. DOI: 10.3238/arztebl.2014.0493

Schad, F, Atxner, J, Buchwald, D, et al. Intratumoral mistletoe (Viscum album L.) therapy in patients with unresectable pancreas carcinoma: a retrospective analysis. Integr Cancer Ther. 2014;13(4):332-340. doi:10.1177/1534735413513637 
Google Scholar | SAGE Journals | ISI

 

Tröger W, Galun D, Reif M, Schumann A, Stankovic N and Milicevic M. Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival. Eur J Cancer, 2013;49:3788-3797. DOI: 10.1016/j.ejca.2013.06.043

 

Matthes H, Friedel WE, Bock PR and Zänker KS. Molecular mistletoe therapy: friend or foe in established anti-tumor protocols? A multicenter, controlled, retrospective pharmaco-epidemiological study in pancreas cancer. Curr Mol Med, 2010;10:430-439. DOI: 10.2174/156652410791317057

Huber, R, Barth, H, Schmitt-Gräff, A, Klein, R. Hypereosinophilia induced by high-dose intratumoral and peritumoral mistletoe application to a patient with pancreatic carcinoma. J Altern Complement Med. 2000;6(4):305-310. doi:10.1089/10755530050120664 Google Scholar | Crossref | Medline

bottom of page